Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boehringer ingelheim
5
×
life sciences
national blog main
biotech
boston blog main
boston top stories
eli lilly
san francisco blog main
san francisco top stories
cancer
clinical trials
indiana blog main
indiana top stories
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
wisconsin blog main
wisconsin top stories
boston
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
fda
merck
moderna
national
pfizer
raleigh-durham blog main
raleigh-durham top stories
renaissance capital
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
abbvie
What
companies
5
×
bio
cancer
deal
life
medicines
pharmaceutical
rna
roundup
science
week
abandoning
ago
approved
arena’s
baggage
bets
black
bounty
cig
combo
comeback
comes
continue
corner
cut
cuts
date
dating
deals
debut
delivered
development
diamond
diamond’s
dicerna
effective
enticed
evidence
expressing
Language
unset
Current search:
companies
×
" boehringer ingelheim "
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines